Bank Julius Baer & Co’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $451K | Buy |
17,008
+9,930
| +140% | +$263K | ﹤0.01% | 394 |
|
2025
Q1 | $193K | Buy |
7,078
+2,098
| +42% | +$57.3K | ﹤0.01% | 427 |
|
2024
Q4 | $221K | Buy |
4,980
+345
| +7% | +$15.3K | ﹤0.01% | 416 |
|
2024
Q3 | $348K | Buy |
+4,635
| New | +$348K | ﹤0.01% | 363 |
|
2021
Q2 | – | Sell |
-6,400
| Closed | -$40K | – | 877 |
|
2021
Q1 | $40K | Sell |
6,400
-1,593
| -20% | -$9.96K | ﹤0.01% | 689 |
|
2020
Q4 | $45K | Buy |
7,993
+2,993
| +60% | +$16.9K | ﹤0.01% | 696 |
|
2020
Q3 | $29K | Hold |
5,000
| – | – | ﹤0.01% | 642 |
|
2020
Q2 | $36K | Sell |
5,000
-1
| -0% | -$7 | ﹤0.01% | 587 |
|
2020
Q1 | $23K | Buy |
+5,001
| New | +$23K | ﹤0.01% | 578 |
|